B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

PRMT3

MOLECULAR TARGET

protein arginine methyltransferase 3

UniProt: O60678NCBI Gene: 101961 compounds

PRMT3 (protein arginine methyltransferase 3) is targeted by 1 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting PRMT3

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1s adenosylhomocysteine1.393

About PRMT3 as a Drug Target

PRMT3 (protein arginine methyltransferase 3) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 1 compounds with documented PRMT3 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

PRMT3 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.